Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156848 | SCV000206569 | uncertain significance | not specified | 2015-11-19 | criteria provided, single submitter | clinical testing | The p.Thr653Ile variant in RBM20 has been identified by our laboratory in 1 Cauc asian individual with HCM, and has also been identified in 3/6614 European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ). Computational prediction tools and conservation analysis suggest that the p.T hr653Ile variant may impact the protein, though this information is not predicti ve enough to determine pathogenicity. In summary, the clinical significance of t he p.Thr653Ile variant is uncertain. |
Gene |
RCV000766690 | SCV000236349 | uncertain significance | not provided | 2022-11-16 | criteria provided, single submitter | clinical testing | Reported in an individual with DCM and an individual with HCM, however, additional patient-specific data were not described (Gigli et al., 2019; van Lint et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30847666, 31514951, 32917565, 34823266, 35893073, HolmstromL2022[Preprint]) |
Labcorp Genetics |
RCV001081755 | SCV000824919 | likely benign | Dilated cardiomyopathy 1DD | 2024-12-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415682 | SCV002722083 | likely benign | Cardiovascular phenotype | 2023-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001081755 | SCV003813789 | uncertain significance | Dilated cardiomyopathy 1DD | 2022-06-09 | criteria provided, single submitter | clinical testing |